News
The acquisition was announced on May 27 th with a price of $25 per share, which represents a 34.6% premium over the 30-day ...
But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. So should Immuneering (NASDAQ:IMRX) shareholders be worried about its cash burn? For the ...
Given this risk, we thought we'd take a look at whether Kalaris Therapeutics (NASDAQ:KLRS) shareholders should be worried about its cash burn. In this report, we will consider the company's annual ...
U.S. stock futures pointed to a slightly weaker open when trading resumes, even after President Trump's delay to a decision on U.S. involvement in the Israel-Iran conflict improved risk sentiment a ...
Salesforce drives growth with AI-powered Agentforce, expanding margins and CRM leadership. Read more on CRM stock and its buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results